<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34059832</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway.</ArticleTitle><Pagination><StartPage>1077</StartPage><EndPage>1088</EndPage><MedlinePgn>1077-1088</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-021-00859-9</ELocationID><Abstract><AbstractText>Nucleocytoplasmic transport (NCT) decline occurs with aging and neurodegeneration. Here, we investigated the NCT pathway in models of amyotrophic lateral sclerosis-fused in sarcoma (ALS-FUS). Expression of ALS-FUS led to a reduction in NCT and nucleoporin (Nup) density within the nuclear membrane of human neurons. FUS and Nups were found to interact independently of RNA in cells and to alter the phase-separation properties of each other in vitro. FUS-Nup interactions were not localized to nuclear pores, but were enriched in the nucleus of control neurons versus the cytoplasm of mutant neurons. Our data indicate that the effect of ALS-linked mutations on the cytoplasmic mislocalization of FUS, rather than on the physiochemical properties of the protein itself, underlie our reported NCT defects. An aberrant interaction between mutant FUS and Nups is underscored by studies in Drosophila, whereby reduced Nup expression rescued multiple toxic FUS-induced phenotypes, including abnormal nuclear membrane morphology in neurons.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Yen-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kumar</LastName><ForeName>Meenakshi Sundaram</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-8846-6953</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ramesh</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Child Neurology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Eric N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Division of Child Neurology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Aivi T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0003-1809-9451</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Boram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonough</LastName><ForeName>Justin A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skarnes</LastName><ForeName>William C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Gonzalez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landers</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fawzi</LastName><ForeName>Nicolas L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0001-5483-0577</Identifier><AffiliationInfo><Affiliation>Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>Ian R A</ForeName><Initials>IRA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0002-4589-1180</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nickerson</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worcester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunwald</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9067-804X</Identifier><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Udai B</ForeName><Initials>UB</Initials><Identifier Source="ORCID">0000-0002-6267-0179</Identifier><AffiliationInfo><Affiliation>Division of Child Neurology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosco</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-3735-3729</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA. Daryl.Bosco@umassmed.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA. Daryl.Bosco@umassmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA047733</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS101661</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS108769</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS091860</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM118530</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072979</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG064940</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS081303</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS078145</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS100055</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM123541</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS111768</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028861">Nuclear Pore Complex Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028861" MajorTopicYN="N">Nuclear Pore Complex Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>DECLARATION OF INTERESTS. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34059832</ArticleId><ArticleId IdType="mid">NIHMS1774891</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pii">10.1038/s41593-021-00859-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frey S, Richter RP &amp; G&#xf6;rlich D FG-Rich Repeats of Nuclear Pore Proteins Form a Three-Dimensional Meshwork with Hydrogel-Like Properties. Science 314, 815&#x2013;817 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17082456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH &amp; Fawzi NL Physiological, Pathological, and Targetable Membraneless Organelles in Neurons. Trends in Neurosciences 42, 693&#x2013;708 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6779520</ArticleId><ArticleId IdType="pubmed">31493925</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB &amp; G&#xf6;rlich D Transport Selectivity of Nuclear Pores, Phase Separation, and Membraneless Organelles. Trends Biochem. Sci 41, 46&#x2013;61 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26705895</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo MA, Raices M, Panowski SH &amp; Hetzer MW Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136, 284&#x2013;295 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J et al. Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. Stem Cell 17, 705&#x2013;718 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929130</ArticleId><ArticleId IdType="pubmed">26456686</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle N et al. Nuclear pore complexes form immobile networks and have a very low turnover in live mammalian cells. J. Cell Biol 154, 71&#x2013;84 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2196857</ArticleId><ArticleId IdType="pubmed">11448991</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama BH et al. Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures. Cell 154, 971&#x2013;982 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788602</ArticleId><ArticleId IdType="pubmed">23993091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama K et al. Calpain-Dependent Degradation of Nucleoporins Contributes to Motor Neuron Death in a Mouse Model of Chronic Excitotoxicity. J. Neurosci 37, 8830&#x2013;8844 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596668</ArticleId><ArticleId IdType="pubmed">28821644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S &amp; Dormann D Nucleocytoplasmic transport defects in neurodegeneration &#x2014; Cause or consequence? Seminars in Cell &amp; Developmental Biology (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31152789</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci 18, 1226&#x2013;1229 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep 6, 20877 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN et al. G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD. Neuron 107, 1124&#x2013;1440 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C-C et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci 79, 1 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampetruzzi A et al. Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nature Communications 10, 3827&#x2013;15 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6707192</ArticleId><ArticleId IdType="pubmed">31444357</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RRK, Ward CL &amp; Bosco DA Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro 6, 1&#x2013;18 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4189536</ArticleId><ArticleId IdType="pubmed">25289647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841&#x2013;2857 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner AC et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science 351, 173&#x2013;176 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;rlich D &amp; Mattaj IW Nucleocytoplasmic transport. Science 271, 1513&#x2013;1518 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8599106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodiha M, Chu A, Matusiewicz N &amp; Stochaj U Multiple mechanisms promote the inhibition of classical nuclear import upon exposure to severe oxidative stress. Cell Death Differ. 11, 862&#x2013;874 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15088071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet 19, 4160&#x2013;4175 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM et al. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS. Hum. Mol. Genet 28, 2143&#x2013;2160 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6586143</ArticleId><ArticleId IdType="pubmed">30806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassany A &amp; Gerace L Reconstitution of nuclear import in permeabilized cells. Methods Mol. Biol 464, 181&#x2013;205 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261132</ArticleId><ArticleId IdType="pubmed">18951186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischbein M et al. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing. J. Biol. Chem 294, 10194&#x2013;10210 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664169</ArticleId><ArticleId IdType="pubmed">31092554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushansky LJ
Investigating the Effects of Mutant FUS on Stress Response in Amyotrophic Lateral Sclerosis. Master Thesis. University of Massachusetts Medical School. (2015). (https://escholarship.umassmed.edu/gsbs_diss/792/)</Citation></Reference><Reference><Citation>Khosravi B et al. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72ALS/FTLD. Hum. Mol. Genet 26, 790&#x2013;800 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H et al. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nature Communications 9, 3683&#x2013;18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M et al. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim. Biophys. Acta 1862, 2004&#x2013;2014 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke KA, Janke AM, Rhine CL &amp; Fawzi NL Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. Mol. Cell 60, 231&#x2013;241 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron 88, 678&#x2013;690 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918&#x2013;921 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter DSW et al. Intrinsically Disordered Regions Can Contribute Promiscuous Interactions to RNP Granule Assembly. Cell Rep 22, 1401&#x2013;1412 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5824733</ArticleId><ArticleId IdType="pubmed">29425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis LI &amp; Blobel G Nuclear pore complex contains a family of glycoproteins that includes p62: glycosylation through a previously unidentified cellular pathway. Proc. Natl. Acad. Sci. U.S.A 84, 7552&#x2013;7556 (1987).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299337</ArticleId><ArticleId IdType="pubmed">3313397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes VC, Reidenbach S &amp; Franke WW Cytoplasmic annulate lamellae in cultured cells: composition, distribution, and mitotic behavior. Cell Tissue Res. 284, 177&#x2013;191 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8625385</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood JM, Becker KA, Stein GS &amp; Nickerson JA The Ultrastructural Signature of Human Embryonic Stem Cells. J. Cell. Biochem 118, 764&#x2013;774 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558502</ArticleId><ArticleId IdType="pubmed">27632380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RRK et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci Rep 7, 115&#x2013;13 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson NA et al. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet 20, 2510&#x2013;2523 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I et al. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nature Communications 10, 5583&#x2013;20 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6898697</ArticleId><ArticleId IdType="pubmed">31811140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell 2, 477&#x2013;486 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3563268</ArticleId><ArticleId IdType="pubmed">21748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R et al. Fusgene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve 42, 170&#x2013;176 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2969843</ArticleId><ArticleId IdType="pubmed">20544928</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ahin A et al. Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and Loss-of-Function Components. Genetics 205, 707&#x2013;723 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289846</ArticleId><ArticleId IdType="pubmed">27974499</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi KY et al. Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. U.S.A 114, 1111&#x2013;1117 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J et al. C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci Rep 9, 15728&#x2013;10 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron 102, 321&#x2013;338.e8 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M et al. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proceedings of the National Academy of Sciences 115, E11904&#x2013;E11913 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Aizawa H, Teramoto S, Akamatsu M &amp; Kwak S Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons. Sci Rep 7, 3643 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5206745</ArticleId><ArticleId IdType="pubmed">28045133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra A &amp; Hetzer MW Nuclear pore proteins and the control of genome functions. Genes Dev. 29, 337&#x2013;349 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335290</ArticleId><ArticleId IdType="pubmed">25691464</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep 8, 920 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J et al. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet 27, 4103&#x2013;4116 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S-Y et al. Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy. Cell Stem Cell 17, 569&#x2013;584 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839185</ArticleId><ArticleId IdType="pubmed">26321202</ArticleId></ArticleIdList></Reference><Reference><Citation>Skarnes WC, Pellegrino E &amp; McDonough JA Improving homology-directed repair efficiency in human stem cells. Methods 164&#x2013;165, 18&#x2013;28 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31216442</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM et al. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics. Molecular Neurodegeneration 2016 11:1 8, 30&#x2013;18 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766239</ArticleId><ArticleId IdType="pubmed">24090136</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R et al. ALS/FTD associated FUS activates GSK 3&#x3b2; to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Reports 17, 1326&#x2013;1342 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>An H et al. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun 7, 1&#x2013;14 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulouras G et al. EasyFRAP-web: a web-based tool for the analysis of fluorescence recovery after photobleaching data. Nucleic Acids Res. 46, W467&#x2013;W472 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030846</ArticleId><ArticleId IdType="pubmed">29901776</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B et al. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer&#x2019;s Disease. Neuron 99, 925&#x2013;940.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240334</ArticleId><ArticleId IdType="pubmed">30189209</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 36, 2951&#x2013;2967 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859&#x2013;863 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N et al. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3. Acta Neuropathol Commun 8, 1182 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603783</ArticleId><ArticleId IdType="pubmed">33129345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega JA et al. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity. Neuron 106, 90&#x2013;107.e13 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272217</ArticleId><ArticleId IdType="pubmed">32059759</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Bardai FH &amp; Feany MB Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Current biology : CB 26, 129&#x2013;136 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713335</ArticleId><ArticleId IdType="pubmed">26725200</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD &amp; Livak KJ Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101&#x2013;1108 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134, 65&#x2013;78 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>